Tight Glycaemic Control in Scottish Intensive Care Units

Malmberg K Ryden L Hamsten A . Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI (Diabetes Insulin-Glucose in Acute Myocardial Infarction) Study Group. Eur Heart J 1996; 17: 1337–1344.

Scott J. F. ; Gray C. S. ; O'Connell J. E. ; Alberti K. G. M. M. Glucose and insulin therapy in acute stroke; why delay further? Qjm 1998; 91: 511–515.

Laird AM Miller PR Kilgo PD Meredith JW Chang MC . Relationship of early hyperglycemia to mortality in trauma patients. J Trauma-Injury Infection & Critical Care 2004; 56: 1058–62.

Van den Berghe G Wouters P Weekers F . Intensive Insulin Therapy in Critically III Patients. NEJM 2001. 345: 1359–1367.

Cariou A Vinsonneau C Dhainaut J-F . Adjunctive therapies in sepsis: An evidence-based review. CCM 2004; 32: S562–S570.

The Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342: 1301–1308.

Bernard GR Vincent JL Laterre PF : Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699–709.

Annane D. Sebille V. Charpentier C. . Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288 (7): 862–71.

http://www.survivingsepsis.org/.